HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells.

Abstract
Numerous reports suggest that IL-6 promotes survival and proliferation of multiple myeloma (MM) cells through the phosphorylation of a cell signaling protein, STAT3. Thus, agents that suppress STAT3 phosphorylation have potential for the treatment of MM. In the present report, we demonstrate that curcumin (diferuloylmethane), a pharmacologically safe agent in humans, inhibited IL-6-induced STAT3 phosphorylation and consequent STAT3 nuclear translocation. Curcumin had no effect on STAT5 phosphorylation, but inhibited the IFN-alpha-induced STAT1 phosphorylation. The constitutive phosphorylation of STAT3 found in certain MM cells was also abrogated by treatment with curcumin. Curcumin-induced inhibition of STAT3 phosphorylation was reversible. Compared with AG490, a well-characterized Janus kinase 2 inhibitor, curcumin was a more rapid (30 min vs 8 h) and more potent (10 micro M vs 100 micro M) inhibitor of STAT3 phosphorylation. In a similar manner, the dose of curcumin completely suppressed proliferation of MM cells; the same dose of AG490 had no effect. In contrast, a cell-permeable STAT3 inhibitor peptide that can inhibit the STAT3 phosphorylation mediated by Src blocked the constitutive phosphorylation of STAT3 and also suppressed the growth of myeloma cells. TNF-alpha and lymphotoxin also induced the proliferation of MM cells, but through a mechanism independent of STAT3 phosphorylation. In addition, dexamethasone-resistant MM cells were found to be sensitive to curcumin. Overall, our results demonstrated that curcumin was a potent inhibitor of STAT3 phosphorylation, and this plays a role in the suppression of MM proliferation.
AuthorsAlok C Bharti, Nicholas Donato, Bharat B Aggarwal
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 171 Issue 7 Pg. 3863-71 (Oct 01 2003) ISSN: 0022-1767 [Print] United States
PMID14500688 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA-Binding Proteins
  • Growth Inhibitors
  • Interferon-alpha
  • Interleukin-6
  • Milk Proteins
  • Oligopeptides
  • STAT1 Transcription Factor
  • STAT1 protein, human
  • STAT3 Transcription Factor
  • STAT3 protein, human
  • STAT5 Transcription Factor
  • Trans-Activators
  • Tyrphostins
  • alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide
  • Curcumin
Topics
  • Active Transport, Cell Nucleus (drug effects)
  • Cell Line
  • Cell Line, Tumor
  • Cell Membrane Permeability (drug effects)
  • Cell Nucleus (drug effects, metabolism)
  • Curcumin (metabolism, pharmacology)
  • DNA-Binding Proteins (antagonists & inhibitors, metabolism)
  • Growth Inhibitors (metabolism, pharmacology)
  • Humans
  • Interferon-alpha (antagonists & inhibitors, pharmacology)
  • Interleukin-6 (antagonists & inhibitors, pharmacology)
  • Milk Proteins
  • Multiple Myeloma (metabolism, pathology)
  • Oligopeptides (metabolism, pharmacology)
  • Phosphorylation (drug effects)
  • STAT1 Transcription Factor
  • STAT3 Transcription Factor
  • STAT5 Transcription Factor
  • Signal Transduction (drug effects)
  • Trans-Activators (antagonists & inhibitors, metabolism)
  • Tyrphostins (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: